US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US ENT Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$4.03 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $10.39 Bn | — | — |
| 2025 (base) | $10.77 Bn | +$374.1 Mn | — |
| 2026 (forecast) | $11.15 Bn | +$387.6 Mn | +3.6% |
| 2027 (forecast) | $11.55 Bn | +$401.5 Mn | +7.3% |
| 2028 (forecast) | $11.97 Bn | +$416.0 Mn | +11.2% |
| 2029 (forecast) | $12.40 Bn | +$431.0 Mn | +15.2% |
| 2030 (forecast) | $12.85 Bn | +$446.5 Mn | +19.3% |
| 2031 (forecast) | $13.31 Bn | +$462.5 Mn | +23.6% |
| 2032 (forecast) | $13.79 Bn | +$479.2 Mn | +28.1% |
| 2033 (forecast) | $14.29 Bn | +$496.4 Mn | +32.7% |
| 2034 (forecast) | $14.80 Bn | +$514.3 Mn | +37.5% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
ENT devices diagnose and treat ear, nose and throat problems, from scopes and balloons to hearing implants.
Key segments of the ENT Devices market include product (Diagnostic Scopes, Balloon Sinus Dilation and Powered Surgical Instruments) and setting (Hospitals, ENT Clinics and Ambulatory Surgery Centers).
Rising rates of sleep apnea, sinus disease and hearing loss, an ageing population and less invasive treatments are driving the ENT Devices market.
Home-based diagnosis, smaller connected devices and office-based procedures give the ENT Devices market room to grow.
Device costs, patients stopping therapy, limited reimbursement and supply issues after recalls hold back the ENT Devices market.
The ENT Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how ENT Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.
What doctors and scientists are doing in ENT Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
US · 2 shared keywords
US · 2 shared keywords
US · 2 shared keywords
US · 1 shared keyword
US · 1 shared keyword
US · 1 shared keyword
Digital Health · US
Digital Health · US
Healthcare Services · US
Healthcare Services · US
Pharmaceuticals · US
Pharmaceuticals · US